<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-17T05:49:43Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2445/124263" metadataPrefix="qdc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2445/124263</identifier><datestamp>2025-12-05T11:56:12Z</datestamp><setSpec>com_2072_1057</setSpec><setSpec>col_2072_478916</setSpec><setSpec>col_2072_478917</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>E-cadherin: A determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness</dc:title>
   <dc:creator>Rosso, Marina</dc:creator>
   <dc:creator>Majem, Blanca</dc:creator>
   <dc:creator>Devis, Laura</dc:creator>
   <dc:creator>Lapyckyj, Lara</dc:creator>
   <dc:creator>Besso, María José</dc:creator>
   <dc:creator>Llauradó, Marta</dc:creator>
   <dc:creator>Abascal, María Florencia</dc:creator>
   <dc:creator>Matos, María Laura</dc:creator>
   <dc:creator>Lanau, Lucia</dc:creator>
   <dc:creator>Castellví, Josep</dc:creator>
   <dc:creator>Sánchez, José Luis</dc:creator>
   <dc:creator>Pérez Benavente, Asunción</dc:creator>
   <dc:creator>Gil Moreno, Antonio</dc:creator>
   <dc:creator>Reventós Puigjaner, Jaume</dc:creator>
   <dc:creator>Santamaria Margalef, Anna</dc:creator>
   <dc:creator>Rigau, Marina</dc:creator>
   <dc:creator>Hebe Vazquez Levin, Mónica</dc:creator>
   <dc:subject>Càncer d'ovari</dc:subject>
   <dc:subject>Ascites</dc:subject>
   <dc:subject>Expressió gènica</dc:subject>
   <dc:subject>Ovarian cancer</dc:subject>
   <dc:subject>Gene expression</dc:subject>
   <dcterms:abstract>Ovarian cancer (OC) is the fifth cancer death cause in women worldwide. The malignant nature of this disease stems from its unique dissemination pattern. Epithelial-to-mesenchymal transition (EMT) has been reported in OC and downregulation of Epithelial cadherin (E-cadherin) is a hallmark of this process. However, findings on the relationship between E-cadherin levels and OC progression, dissemination and aggressiveness are controversial. In this study, the evaluation of E-cadherin expression in an OC tissue microarray revealed its prognostic value to discriminate between advanced-and early-stage tumors, as well as serous tumors from other histologies. Moreover, E-cadherin, Neural cadherin (N-cadherin), cytokeratins and vimentin expression was assessed in TOV-112, SKOV-3, OAW-42 and OV-90 OC cell lines grown in monolayers and under anchorage-independent conditions to mimic ovarian tumor cell dissemination, and results were associated with cell aggressiveness. According to these EMT-related markers, cell lines were classified as mesenchymal (M; TOV-112), intermediate mesenchymal (IM; SKOV-3), intermediate epithelial (IE; OAW-42) and epithelial (E; OV-90). M-and IM-cells depicted the highest migration capacity when grown in monolayers, and aggregates derived from M-and IM-cell lines showed lower cell death, higher adhesion to extracellular matrices and higher invasion capacity than E- antigen 125 levels more than 500 U/mL and platinum-free intervals less than 6 months. Altogether, E-cadherin expression levels were found relevant for the assessment of OC progression and aggressiveness.and IE-aggregates. The analysis of E-cadherin, N-cadherin, cytokeratin 19 and vimentin mRNA levels in 20 advanced-stage high-grade serous human OC ascites showed an IM phenotype in all cases, characterized by higher proportions of N-to E-cadherin and vimentin to cytokeratin 19. In particular, higher E-cadherin mRNA levels were associated with cancer antigen 125 levels more than 500 U/mL and platinum-free intervals less than 6 months. Altogether, E-cadherin expression levels were found relevant for the assessment of OC progression and aggressiveness.</dcterms:abstract>
   <dcterms:issued>2018-09-04T13:59:36Z</dcterms:issued>
   <dcterms:issued>2018-09-04T13:59:36Z</dcterms:issued>
   <dcterms:issued>2017-09-21</dcterms:issued>
   <dcterms:issued>2018-07-24T12:00:59Z</dcterms:issued>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:relation>Reproducció del document publicat a: https://doi.org/10.1371/journal.pone.0184439</dc:relation>
   <dc:relation>PLos One, 2017, vol. 12, num. 9, p. e0184439</dc:relation>
   <dc:relation>https://doi.org/10.1371/journal.pone.0184439</dc:relation>
   <dc:relation>info:eu-repo/grantAgreement/EC/FP7/269285/EU//PROTBIOFLUID</dc:relation>
   <dc:rights>cc by (c) Rosso et al., 2017</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by/3.0/es/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:publisher>Public Library of Science (PLoS)</dc:publisher>
   <dc:source>Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))</dc:source>
</qdc:qualifieddc></metadata></record></GetRecord></OAI-PMH>